
Sign up to save your podcasts
Or
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
4.8
6262 ratings
Heather Turner, CEO at Carmot Therapeutics, speaks with Venrock partner Nimish Shah to discuss her time as CEO. Turner shares how she guided the company through its acquisition by Roche, advice for other CEOs on the verge of an acquisition, her perspective on the GLP-1 market and what excites her about the future of biotech.
1,284 Listeners
2,162 Listeners
1,043 Listeners
978 Listeners
1,795 Listeners
2,288 Listeners
3,990 Listeners
121 Listeners
318 Listeners
5,958 Listeners
1,543 Listeners
30 Listeners
144 Listeners
18 Listeners
50 Listeners